Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$1.62B |
| 2 |
PayPal
PYPL
|
+$1.06B |
| 3 |
AT&T
T
|
+$933M |
| 4 |
Amazon
AMZN
|
+$653M |
| 5 |
Electronic Arts
EA
|
+$641M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$1.71B |
| 2 |
Apple
AAPL
|
+$1.57B |
| 3 |
AGN
Allergan plc
AGN
|
+$1.45B |
| 4 |
FedEx
FDX
|
+$1.31B |
| 5 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$1.27B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.04% |
| 2 | Financials | 15.32% |
| 3 | Technology | 13.93% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alphabet (Google) Class C
GOOG
$4.11T
| $20.5B | 2.91% |
656,137,200
+19,376,980
| +3% | +$595M |
|
|
2
Apple
AAPL
$4.97T
| $18.5B | 2.63% |
670,444,036
-53,371,928
| -7% | -$1.57B |
|
3
Meta Platforms (Facebook)
META
$1.49T
| $13.1B | 1.86% |
145,354,000
-304,947
| -0.2% | -$28M |
|
|
4
Amazon
AMZN
$2.44T
| $8.5B | 1.21% |
332,251,800
+25,821,160
| +8% | +$653M |
|
5
Gilead Sciences
GILD
$165B
| $8.06B | 1.15% |
82,082,369
-4,440,739
| -5% | -$493M |
|
6
Wells Fargo
WFC
$254B
| $7.9B | 1.12% |
153,837,698
-10,294,031
| -6% | -$566M |
|
7
JPMorgan Chase
JPM
$916B
| $7.86B | 1.12% |
128,881,195
-4,310,239
| -3% | -$282M |
|
8
Visa
V
$701B
| $7.38B | 1.05% |
105,976,936
+2,064,686
| +2% | +$147M |
|
9
Salesforce
CRM
$154B
| $6.68B | 0.95% |
96,263,246
+464,416
| +0.5% | +$32.9M |
|
10
UnitedHealth
UNH
$382B
| $6.64B | 0.95% |
57,232,845
+894,918
| +2% | +$107M |
|
11
Starbucks
SBUX
$119B
| $5.83B | 0.83% |
102,651,241
-4,171,955
| -4% | -$234M |
|
12
Microsoft
MSFT
$2.9T
| $5.79B | 0.82% |
130,903,239
-20,348,064
| -13% | -$914M |
|
13
Berkshire Hathaway Class A
BRK.A
$1.1T
| $5.7B | 0.81% |
29,208
+11
| +0% | +$2.27M |
|
14
CVS Health
CVS
$135B
| $5.67B | 0.81% |
58,812,530
+896,659
| +2% | +$94.3M |
|
15
GE Aerospace
GE
$364B
| $5.62B | 0.8% |
46,480,491
+1,231,526
| +3% | +$151M |
|
16
Medtronic
MDT
$112B
| $5.19B | 0.74% |
77,508,580
+3,651,755
| +5% | +$269M |
|
17
Nike
NKE
$64.1B
| $4.99B | 0.71% |
81,223,468
-2,777,046
| -3% | -$157M |
|
18
Mastercard
MA
$498B
| $4.87B | 0.69% |
54,039,335
+1,500,131
| +3% | +$141M |
|
|
19
Biogen
BIIB
$30.9B
| $4.83B | 0.69% |
16,563,800
-5,174,594
| -24% | -$1.71B |
|
20
Johnson & Johnson
JNJ
$640B
| $4.8B | 0.68% |
51,400,591
-933,608
| -2% | -$90.3M |
|
21
Bank of America
BAC
$429B
| $4.73B | 0.67% |
303,820,795
-30,112,581
| -9% | -$507M |
|
22
Walt Disney
DIS
$171B
| $4.65B | 0.66% |
45,451,537
-8,156,798
| -15% | -$888M |
|
23
Citigroup
C
$213B
| $4.47B | 0.64% |
90,154,670
+835,197
| +0.9% | +$45.6M |
|
|
AGN
24
DELISTED
Allergan plc
AGN
| $4.38B | 0.62% |
16,130,071
-4,704,721
| -23% | -$1.45B |
|
25
Teva Pharmaceuticals
TEVA
$40.4B
| $4.11B | 0.59% |
72,846,432
+7,852,764
| +12% | +$509M |
|
Similar funds
Fidelity Investments's Q3 2015 Portfolio in Review
As of Q3 2015, Fidelity Investments held 2,879 positions worth $702B, down 10% from $780B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Fidelity Investments's Q3 2015 filing shows 152 new, 1,160 increased, 1,058 reduced and 167 closed positions. Its largest new stake was WestRock Company: 30,198,306 shares worth $1.4B. The largest sale was Biogen, an estimated $1.71B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Financials and Technology.
- Fidelity Investments's largest Q3 2015 buy was WestRock Company: 30,198,306 shares worth $1.4B.
- Fidelity Investments added most to AT&T in Q3 2015, an estimated $933M increase.
- Fidelity Investments's biggest Q3 2015 reduction was Biogen, cutting an estimated $1.71B.
- Fidelity Investments fully exited ROCK-TENN COMPANY CL-A in Q3 2015, selling an estimated $1.27B.
- Fidelity Investments's ten largest holdings make up 15% of its $702B portfolio in Q3 2015.
- Fidelity Investments opened 152 new positions and closed 167 in Q3 2015.
- Fidelity Investments's portfolio value fell 10% quarter-over-quarter to $702B.
Based on Fidelity Investments's 13F filing for Q3 2015, filed 10 Nov 2015.